Photonic Pharma

About:

Photonic Pharma is an early phase of drug development

Website: https://www.photonicpharma.com

Top Investors: National Institutes of Health, Small Business Innovation Research

Description:

Photonic Pharma is an early phase of drug development which uses a game-changing technology platform that combines breakthroughs in fluorescence biosensor engineering and fluorescence lifetime detection in living cells.

Total Funding Amount:

$1.09M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Minneapolis, Minnesota, United States

Founded Date:

2014-01-01

Founders:

David D. Thomas, Jennifer Jewell Thomas, Razvan L. Cornea

Number of Employees:

1-10

Last Funding Date:

2021-01-15

IPO Status:

Private

Industries: